The Mission Marketing Share Discussion Threads

[dr biotech] 03/8/2016 12:04

Heading back to the multi year low again for no reason. Just wonder why there is such a disconnect between what the co says and how the market values it. Just have to hold and hope.

[ricky777] 21/7/2016 19:49

Wouldn't it nice if we were presented with an aggressive t/o approach! Not starting any rumours, but we can but hope what with this serious undervaluation. Patience is the requirement here.

[joe say] 21/7/2016 11:44

Dr B - I have

HL as a whole had not received the dividend as of cob yesterday and have been chasing up

[cheshire man] 21/7/2016 11:41

Got mine on the 18th !

[dr biotech] 21/7/2016 11:28

Whilst the co has a mostly UK focus it should also benefit from the drop in sterling - overseas earnings will be worth more.

Joe you should contact HL. Dividend has clearly been paid.

[cheshire man] 21/7/2016 11:05

Very pleased with this update, chart looking good for move north too :-)DYOR etc.

[mfhmfh] 21/7/2016 10:59

Great update today. Liked the following:

'...we again expect both revenue and profit for the first half of 2016 to show double digit growth...benefiting from both organic growth and the acquisitions...'

Despite the double digit growth '...We expect our results for the year to 31 December 2016 to again have a significant bias towards the second half...'

Plus net debt has also fallen.

Looks like Brexit has not impacted the company negatively. I felt we were undervalued pre-Brexit anyway and now represent even better value.

I wonder if we might see any Director buys in the coming days/weeks.

All IMHO

[chinese investor] 21/7/2016 09:53

Good Results !

[davebowler] 21/7/2016 09:51

Finncap;
The Mission Marketing Group* (TMMG): Positive trading update (CORP)
The group has issued a trading update for the six-month period to June 2016. The statement confirms that both revenue and profit have shown double-digit increases over the same period last year through a combination of organic and acquisitive growth. Net debt at the half-year end was £9.4m, implying a net cash inflow of £1.5m despite cash consideration payments of £2.6m. Both the group's leverage ratios reduced during the period and remain well within the limits set by the board. The group's trading profile is traditionally heavily second-half weighted, and we expect that to be a feature again in the current year. Following the statement, our full-year forecasts remain unchanged. The group is clearly continuing to trade well and generate cash, and there remains scope for further acquisitions in due course. However, despite this positive profile, the current market valuation implies a significant discount to its sector peers and the wider market, indicating a good investment opportunity. We therefore retain our 60p target price.
Analyst: Mark Paddon

[joe say] 21/7/2016 08:16

We expect our results for the year to 31 December 2016 to again have a significant bias towards the second half and we look forward to further progress over the remainder of the year.

Significant bias after a good H1 - surely way undervalued

And surely they can now pay HL the dividends due for myself and other holders?

[18bt] 21/7/2016 07:39

One day, hopefully soon, these will be recognised for the bargain they are.

[dr biotech] 21/7/2016 07:14

I received mine earlier this week, with the Halifax

Decent enough trading update this morning then. No obvious reason for the 25% decline other than general brexit concerns. Onwards and hopefully upwards. It's the only small cap I hold, makes up about 4% of the total so not insignificant.

[joe say] 20/7/2016 13:47

Dividend not received by Hargreaves Lansdown - what's the issue then?

[mfhmfh] 19/7/2016 09:52

emailed the company last week. received a very quick response as always and told trading update will be late this week or early next week (last year was on 22nd July). Hoping for good news.

[ricky777] 11/7/2016 22:30

News soon. Hope it's good!😄

[josephrobert] 23/5/2016 19:37

Support @ 40p again, P/E seems impressively cheap for a company that is growing nicely, with low levels of debt and positive cash flow. If we see a positive surprise on earnings growth I think we shall see a change in the trend of the share price

[ricky777] 05/5/2016 19:41

Doubled my holding today. Have always considered 40p to be a base price with at least 25% uplift come interim results. Potentially 3.5 % dividend at end of this year. Good luck to all holders.

[dr biotech] 28/4/2016 16:47

back down to c40 then as the cycle continues. Not really sure what will get this one going.

[pj 1] 22/4/2016 16:17

Seems a bit more buying pressure here recently so I took some more today. L2 looking better but can change quickly in illiquid stocks.

[cheshire man] 08/4/2016 15:06

Some interest pushing the share price up I see :-)

[cheshire man] 25/3/2016 16:39

Thank's for that GHF,,, very encouraging feedback :-)

[jeff h] 25/3/2016 15:46

A couple of interviews:-





The finnCap analyst sounds impressed.

I recall a couple of years ago David Morgan going on about how he hated debt
...it's not stopped acquisitions, though on a lot smaller scale than the previous management.

[dr biotech] 25/3/2016 09:23

Thanks GHF.